WeVote

Bill

Bill

HB 611

Mississippi Medical Cannabis Act; revise provisions relating to.

2025 Regular Session Introduced by Lee Yancey

Mississippi bill revising medical cannabis regulations died in Senate committee without final passage after House approval of amended provisions.

Died In Committee
0
WeVote Research Nonpartisan
Bill Summary · HB 611

Legislative bill overview

HB 611 proposes revisions to Mississippi's medical cannabis framework, though the bill summary provided doesn't specify the exact amendments. Based on the legislative history, the House passed a committee substitute version before transmitting it to the Senate, where it was referred to the Medicaid and Public Health and Welfare Committee before ultimately dying in committee.

Why is this important

Medical cannabis policy directly affects patient access to treatment options, state revenue generation, and regulatory oversight. Mississippi's approach to these revisions could impact thousands of patients currently or potentially enrolled in the state's medical cannabis program, as well as industry participants and state budgets.

Potential points of contention

  • Program scope and patient eligibility – Disagreement likely exists over which medical conditions qualify for cannabis treatment and how restrictive or expansive the patient population should be
  • Regulatory and licensing framework – Tensions between ensuring product safety/quality control and avoiding burdensome regulations that limit access or market participation
  • Implementation costs and state oversight – Debate over state resources needed for program administration, testing requirements, and enforcement mechanisms

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.